trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Estrogen therapy for postmenopausal women helps to prevent osteoporosis.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that estrogen therapy for postmenopausal women helps to prevent osteoporosis?

Yes. Estrogen therapy for postmenopausal women helps to prevent osteoporosis by preserving bone mineral density and reducing fracture risk, supported by clinical trials and large-scale cohort studies.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently supports the role of estrogen therapy in preventing or reducing the risk of postmenopausal osteoporosis and related fractures. Cochrane review data and large-scale real-world cohort studies demonstrate a significant reduction in fracture risk among hormone therapy users.

Evidence for · 4
Long-term hormone therapy for perimenopausal and postmenopausal women.
2026
A Cochrane review demonstrates that both estrogen-only and combined hormone therapy reduce the risk of clinical fractures in postmenopausal women.
Get citation
M, B. R., LN, Y., S, M., C, B., A, L., & C, F. (2026). Long-term hormone therapy for perimenopausal and postmenopausal women.. doi.org. https://doi.org/10.1002/14651858.cd004143.pub7

See more details
More for · 3
The potential role and research progress of the gut microbiota-NGF axis in postmenopausal bone homeostasis imbalance.
2026
A review highlights that postmenopausal osteoporosis is characterized by bone remodeling imbalance due to estrogen deficiency.
Get citation
Y, C., D, L., Z, W., J, L., H, Z., & X, X. (2026). The potential role and research progress of the gut microbiota-NGF axis in postmenopausal bone homeostasis imbalance.. doi.org. https://doi.org/10.3389/fimmu.2026.1933248

The multisystem impact of perimenopausal hormonal fluctuations on chronic disease risk.
2026
A review notes that menopausal reductions in estrogen contribute to the pathogenesis of osteoporosis.
Get citation
L, L., L, L., X, W., & W, B. (2026). The multisystem impact of perimenopausal hormonal fluctuations on chronic disease risk.. doi.org. https://doi.org/10.3389/fendo.2026.1894588

Long-term systemic outcomes of postmenopausal hormone replacement therapy by age at menopause: a real-world cohort study.
2026
A large cohort study found that postmenopausal hormone replacement therapy is associated with a lower hazard of compression fractures.
Get citation
TF, L., CH, L., YH, S., YF, C., CT, F., SJ, W., ST, H., CK, L., L, S., SF, H., & TH, L. (2026). Long-term systemic outcomes of postmenopausal hormone replacement therapy by age at menopause: a real-world cohort study.. doi.org. https://doi.org/10.1093/hropen/hoag072

What does the evidence say?

The retrieved literature consistently supports the role of estrogen therapy in preventing or reducing the risk of postmenopausal osteoporosis and related fractures. Cochrane review data and large-scale real-world cohort studies demonstrate a significant reduction in fracture risk among hormone therapy users.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work